Clinical Trial Update: Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports that sildenafil may reduce cardiovascular morbidity and mortality in patients with arterial claudication due to peripheral arter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University Hospital, Angers | Conditions: Peripheral Arterial Disease | Phase 2, Phase 3 | Status: UNKNOWN